1. Estimated 5-year rate of a first major vascular event (MVE), major coronary event (MCE),or vascular death in univariate and multivariate risk subgroups
Heart Protection Study Collaborative Group Lancet 2005;365:1779

2. Total (first and subsequent) vascular and non-vascular outcomes during 5-year mean follow-up
Heart Protection Study Collaborative Group Lancet 2005;365:1779

3. Mean days in hospital and costs of hospitalisation per person during 5-year mean follow-up
Heart Protection Study Collaborative Group Lancet 2005;365:1779

4. Proportional reductions in vascular event costs with simvastatin allocation by prior disease,sex, age,LDL cholesterol,and multivariate risk subgroups
Heart Protection Study Collaborative Group Lancet 2005;365:1779

5. Days on statin and costs of statin per person during 5-year mean follow-up
Heart Protection Study Collaborative Group Lancet 2005;365:1779

6. Statin cost (￡) per person by baseline characteristics during 5-year mean follow-up
Heart Protection Study Collaborative Group Lancet 2005;365:1779

7. Reductions in 5-year vascular event costs (and 95%CI) with simvastatin allocation by baseline risk subgroups
Heart Protection Study Collaborative Group Lancet 2005;365:1779